Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm

doi:10.1001/jamadermatol.2022.6236

Editorial

. 2023 Apr 1;159(4):371-373.

doi: 10.1001/jamadermatol.2022.6236.

Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm

Howa Yeung^{1

2

3}, Anandi N Sheth^{3

4}, Lauren F Collins^{3

4}

Affiliations

¹ Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
² Clinical Resource Hub, Veterans Integrated Service Network (VISN) 7 Southeast Network, Decatur, Georgia.
³ Ponce de Leon Center, Grady Health System, Atlanta, Georgia.
⁴ Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

PMID: 36787146
PMCID: PMC10308498
DOI: 10.1001/jamadermatol.2022.6236

Editorial

Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm

Howa Yeung et al. JAMA Dermatol. 2023.

. 2023 Apr 1;159(4):371-373.

doi: 10.1001/jamadermatol.2022.6236.

Authors

Howa Yeung^{1

2

3}, Anandi N Sheth^{3

4}, Lauren F Collins^{3

4}

Affiliations

¹ Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
² Clinical Resource Hub, Veterans Integrated Service Network (VISN) 7 Southeast Network, Decatur, Georgia.
³ Ponce de Leon Center, Grady Health System, Atlanta, Georgia.
⁴ Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

PMID: 36787146
PMCID: PMC10308498
DOI: 10.1001/jamadermatol.2022.6236

No abstract available

PubMed Disclaimer

Conflict of interest statement

2) All other relationships:

The authors have no additional conflicts of interest to disclose.

Comment in

Reducing HSV-2 Morbidity and Mortality: Routine Serologic Screening Still Not the Best Answer.
Pearlman MD. Pearlman MD. JAMA. 2023 Feb 14;329(6):469-471. doi: 10.1001/jama.2022.24870. JAMA. 2023. PMID: 36786801 No abstract available.

References

1. Asher GN, Feltner C, Harrison WN, Emmanuel S, Caroline R, Jonas DE. Serologic Screening for Genital Herpes Infection: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. 2022. Evidence Synthesis: Number 224.
1. Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Genital Herpes. 2022. Sexually Transmitted Infections Treatment Guidelines, 2021. Accessed December 4, 2022. https://www.cdc.gov/std/treatment-guidelines/herpes.htm
1. Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin, Number 220. Obstet Gynecol. May 2020;135(5):e193–e202. doi:10.1097/AOG.0000000000003840 - DOI - PubMed
1. Binnicker MJ, Espy MJ, Duresko B, Irish C, Mandrekar J. Automated processing, extraction and detection of herpes simplex virus types 1 and 2: A comparative evaluation of three commercial platforms using clinical specimens. J Clin Virol. Apr 2017;89:30–33. doi:10.1016/j.jcv.2017.02.006 - DOI - PubMed
1. Fanfair RN, Zaidi A, Taylor LD, Xu F, Gottlieb S, Markowitz L. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years--United States, 1988 to 2010. Sex Transm Dis. Nov 2013;40(11):860–4. doi:10.1097/OLQ.0000000000000043 - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Asher GN, Feltner C, Harrison WN, Emmanuel S, Caroline R, Jonas DE. Serologic Screening for Genital Herpes Infection: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. 2022. Evidence Synthesis: Number 224.

[2] Asher GN, Feltner C, Harrison WN, Emmanuel S, Caroline R, Jonas DE. Serologic Screening for Genital Herpes Infection: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. 2022. Evidence Synthesis: Number 224.

[3] Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Genital Herpes. 2022. Sexually Transmitted Infections Treatment Guidelines, 2021. Accessed December 4, 2022. https://www.cdc.gov/std/treatment-guidelines/herpes.htm

[4] Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Genital Herpes. 2022. Sexually Transmitted Infections Treatment Guidelines, 2021. Accessed December 4, 2022. https://www.cdc.gov/std/treatment-guidelines/herpes.htm

[5] Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin, Number 220. Obstet Gynecol. May 2020;135(5):e193–e202. doi:10.1097/AOG.0000000000003840 - DOI - PubMed

[6] Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin, Number 220. Obstet Gynecol. May 2020;135(5):e193–e202. doi:10.1097/AOG.0000000000003840 - DOI - PubMed

[7] Binnicker MJ, Espy MJ, Duresko B, Irish C, Mandrekar J. Automated processing, extraction and detection of herpes simplex virus types 1 and 2: A comparative evaluation of three commercial platforms using clinical specimens. J Clin Virol. Apr 2017;89:30–33. doi:10.1016/j.jcv.2017.02.006 - DOI - PubMed

[8] Binnicker MJ, Espy MJ, Duresko B, Irish C, Mandrekar J. Automated processing, extraction and detection of herpes simplex virus types 1 and 2: A comparative evaluation of three commercial platforms using clinical specimens. J Clin Virol. Apr 2017;89:30–33. doi:10.1016/j.jcv.2017.02.006 - DOI - PubMed

[9] Fanfair RN, Zaidi A, Taylor LD, Xu F, Gottlieb S, Markowitz L. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years--United States, 1988 to 2010. Sex Transm Dis. Nov 2013;40(11):860–4. doi:10.1097/OLQ.0000000000000043 - DOI - PubMed

[10] Fanfair RN, Zaidi A, Taylor LD, Xu F, Gottlieb S, Markowitz L. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years--United States, 1988 to 2010. Sex Transm Dis. Nov 2013;40(11):860–4. doi:10.1097/OLQ.0000000000000043 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm

Affiliations

Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm

Authors

Affiliations

Conflict of interest statement

Comment in

Similar articles

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical